Palvella Therapeutics, Inc. (PVLA)
85.66
+3.33
(+4.04%)
USD |
NASDAQ |
Feb 20, 16:00
85.57
-0.09
(-0.11%)
After-Hours: 20:00
Palvella Therapeutics Market Cap : 1.014B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 110.59M |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Madrigal Pharmaceuticals, Inc. | 9.880B |
| Ligand Pharmaceuticals, Inc. | 3.621B |
| Axsome Therapeutics, Inc. | 9.262B |
Market Cap Related Metrics
| Price to Book Value | 26.21 |
| Price | 85.66 |
| Earnings Yield | -7.66% |